Surgical nephrectomy stands a good chance of cure for localised disease but the disease is ultimately fatal if metastatic at presentation. Nevertheless, prolongation of life for patients who have relapsed after removal of their kidney for cancer (or for patients who present with inoperable or metastatic disease) is possible with immunotherapy and/or sorafinib/bevacizumab are the currently most successful.
